Scientific Advisory Board

The Scientific Advisory Board, chaired by Dr. David Rattner, is formed of leading research clinicians and scientists in the areas of biotechnology and medical devices. All of the SAB members have experience in the management of research operations or technology business operations and most are inventors.

David W. Rattner, M.D., Chair

• Chief, Division of General and Gastrointestinal Surgery,  Massachusetts General Hospital.
• Director, Minimally Invasive Surgery, Harvard Medical School.
• Program Director, Operating Room of the Future, Center for Innovative Minimally Invasive Therapy.
• President, Society of American Gastrointestinal and Endoscopic Surgeons

Antonio M. Gotto, Jr., M.D.

• Dean and Provost, Weill Medical College, Cornell University
• Former President, American Heart Association
• Member, Board of Directors, Medtronic, Inc.

Adrian Hobden, Ph.D.

• President, Myriad Pharmaceuticals
• Former Director, Glaxo-Wellcome

Isador Lieberman, M.D., M.B.A.

• Director, Center for Minimally Invasive Surgery,
• Director, Center for Advanced Skills Training, and
• Department of Orthopedics, Cleveland Clinic Foundation

Marc S. Penn, M.D., Ph.D., FACC

• Medical Director, Coronary Intensive Care Unit,
• Director, Experimental Animal Laboratory, and
• Associate Director, Cardiovascular Medicine Training Program, Cleveland Clinic Foundation

Patrick Whitlow, M.D.

• Director, Interventional Cardiology, and
• Departments of Vascular Surgery and Molecular Cardiology, Cleveland Clinic Foundation

James B. Wyngaarden, M.D.

• Former Director, National Institutes of Health
• Former Associate Director, Office of Science Policy, Executive Office of the President
• Vice Chancellor for Health Affairs, Duke University (retired)